CD274 and neoplasm: Interestingly, the administration of the anti-PD-L1 antibody reduced tumor growth by 20.3% in wild type mice compared to the control (Figure 3B), whereas the efficacy of the treatment was considerably superior in Emilin2−/− mice, accounting for a 72.7% reduction inthe tumor growth (Figure 3B).